HR 2038
116th Congress • 2019-2021 (Ended)

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019


HR 2038
Apr 2, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.